Body CompositionNCT03400761
Does Body Composition Predict Running Time?
An observational study of Body Composition and Running Performance, run by University Hospital, Geneva.
Trial summary
Several studies performed in elite endurance athletes have shown that running performance may be determined by a low fat mass in the overall population. The "Course de l'Escalade" occurs yearly during the first week-end of December. This race takes place in the city of Geneva. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Body Composition, Running Performance
- How many people
- 13,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 1999to 31 Dec 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: This is a historical cohort study of prospectively collected measurements of body composition performed by bioelectrical impedance analysis (BIA) at the "Course de l'Escalade", between 1999 and 2017. The "Course de l'Escalade" is a fun race occurring yearly in Geneva, between December 1999 and 2017. The distance of this race is 7.3 km for all men and elite women, and 4.8 km for non-elite women.
Who may be able to join
- All subjects who underwent a measurement of body composition by tetrapolar bioelectrical impedance analyses (BIA) at the "Course de l'Escalade", a fun race occurring yearly in Geneva, between December 1999 and 2017.
Who cannot join
- Measurements of people <18 years at the time of BIA measurement.
- Measurements of people who did not perform or finish the race.
About this study
Several studies performed in elite endurance athletes have shown that running performance may be determined by a low fat mass in the overall population.
The "Course de l'Escalade" occurs yearly during the first week-end of December. This race takes place in the city of Geneva. The distance of this race is 7.3 km for all men and elite women, and 4.8 km for non-elite women. During this race, measurement of body composition by biolelectrical impedance analyses (BIA) were performed in volunteer, between December 1999 and 2017.
Read more
Hypothesis :
We hypothesize that:
- A low fat mass is associated with a slower running time, when adjusting for age, body weight, and habitual physical exercise.
- An increase in fat mass over time increases running time over the years
Objectives :
- To evaluate whether total and regional body composition is associated with running time at the "Course de l'Escalade".
- To determine whether changes in body composition with progressive aging lead to changes in running time.
- Conditions
- Body Composition, Running Performance
What is being measured
The primary outcome is the main question the study is designed to answer.
Association between total and regional body composition and running time at the "Course de l'Escalade"
Body composition measured by bioelectrical impedance analyses. Running time timed.
Measured: One day per year between 1999 and 2017 (i.e. the day of the "Course de l'escalade")
Secondary outcomes (1)
Association between changes in body composition with progressive aging and changes in running time at the "Course de l'Escalade"
Body composition measured by bioelectrical impedance analyses. Running time timed.
Measured: One day per year between 1999 and 2017 (i.e. the day of the "Course de l'escalade")
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jan 2018
- Study start1 Dec 1999
- Primary completion31 Dec 2017
- Study completion31 Dec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Body CompositionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 13,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Geneva
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Genton Graf Laurence, University Hospital, Geneva
- Investigators
- Laurence Genton, Pr. Dr. med, Principal investigator, University Hospital, Geneva
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03400761
- Sponsor's protocol ID
- 2017-01327
- Other IDs
- 2017
- Status last verified
- Jan 2018
- First submitted
- 8 Jan 2018
- Last updated
- 17 Jan 2018
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Genton L, Mareschal J, Norman K, Karsegard VL, Delsoglio M, Pichard C, Graf C, Herrmann FR. Association of phase angle and running performance. Clin Nutr ESPEN. 2020 Jun;37:65-68. doi: 10.1016/j.clnesp.2020.03.020. Epub 2020 Apr 15.
PubMed 32359757
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Body Composition Predict Running Time?
- ClinicalTrials.gov ID
- NCT03400761
- Acronym / sponsor ID
- 2017-01327
- Conditions
- Body Composition, Running Performance
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 13,000 participants (actual)
- Lead sponsor
- University Hospital, GenevaUniversity, hospital or other
- Study start
- 1 Dec 1999 (actual)
- Primary completion
- 31 Dec 2017 (actual)
- Study completion
- 31 Dec 2017 (actual)
- First posted
- 17 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Several studies performed in elite endurance athletes have shown that running performance may be determined by a low fat mass in the overall population.
The "Course de l'Escalade" occurs yearly during the first week-end of December. This race takes place in the city of Geneva. The distance of this race is 7.3 km for all men and elite women, and 4.8 km for non-elite women. During this race, measurement of body composition by biolelectrical impedance analyses (BIA) were performed in volunteer, between December 1999 and 2017.
Hypothesis :
We hypothesize that:
- A low fat mass is associated with a slower running time, when adjusting for age, body weight, and habitual physical exercise.
- An increase in fat mass over time increases running time over the years
Objectives :
- To evaluate whether total and regional body composition is associated with running time at the "Course de l'Escalade".
- To determine whether changes in body composition with progressive aging lead to changes in running time.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- This is a historical cohort study of prospectively collected measurements of body composition performed by bioelectrical impedance analysis (BIA) at the "Course de l'Escalade", between 1999 and 2017. The "Course de l'Escalade" is a fun race occurring yearly in Geneva, between December 1999 and 2017. The distance of this race is 7.3 km for all men and elite women, and 4.8 km for non-elite women.
Key inclusion criteria (1 listed)
- All subjects who underwent a measurement of body composition by tetrapolar bioelectrical impedance analyses (BIA) at the "Course de l'Escalade", a fun race occurring yearly in Geneva, between December 1999 and 2017.
Key exclusion criteria (2 listed)
- Measurements of people <18 years at the time of BIA measurement.
- Measurements of people who did not perform or finish the race.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Association between total and regional body composition and running time at the "Course de l'Escalade"
Time frame: One day per year between 1999 and 2017 (i.e. the day of the "Course de l'escalade")
Body composition measured by bioelectrical impedance analyses. Running time timed.
1 secondary outcome
Association between changes in body composition with progressive aging and changes in running time at the "Course de l'Escalade"
Time frame: One day per year between 1999 and 2017 (i.e. the day of the "Course de l'escalade")
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2018.
- Derived from this study: PubMed 32359757Genton L, Mareschal J, Norman K, Karsegard VL, Delsoglio M, Pichard C, Graf C, Herrmann FR. Association of phase angle and running performance. Clin Nutr ESPEN. 2020 Jun;37:65-68. doi: 10.1016/j.clnesp.2020.03.020. Epub 2020 Apr 15.
Related trials for Body Composition
RecruitingObservational study
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Obesity & Overweight
Active, not recruiting
Effect of Exercise Training on Breastmilk Composition
Obesity
Not yet recruiting
Creatine and Muscle Health in Madrid's Walking Footballers.
Muscle Adaptation, Body Composition
RecruitingPhase 4
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Mild Autonomous Cortisol Secretion (MACS)
RecruitingPhase 2/3
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Type 1 Diabetes, Overweight , Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Laurence Genton, Pr. Dr. med principal investigator
University Hospital, Geneva
Questions about this trial
What is this clinical trial studying?
An observational study of Body Composition and Running Performance, run by University Hospital, Geneva.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Association between total and regional body composition and running time at the "Course de l'Escalade" (time frame: One day per year between 1999 and 2017 (i.e. the day of the "Course de l'escalade")). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03400761, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2018.